








Deep industry expertise in emerging technologies and life sciences
Proven success in capturing millions in tax savings from R&D and state incentives.
Audit-ready methodologies that stand up to scrutiny
Transparent pricing and startup-friendly engagement models.
Advisory support that scales with your business-from seed to IPO




Engagements with audit service Worcester, audit service Lowell, and audit service Quincy will assist in streamlining any potential audit with clean financial books, reconciliations, and backed documentation.



Tech and biotech companies face complex challenges such as R&D tax credits, clinical trials, equity compensation, and regulatory compliance. Specialized tax firms understand industry-specific rules, funding structures, and incentives that general tax advisors often miss.
R&D tax credits can significantly reduce federal and Massachusetts tax liabilities. Specialized tax firms help identify qualifying projects, calculate eligible expenses, and prepare audit-ready documentation to maximize refundable and non-refundable credits.
Each funding source has unique tax and reporting implications. Experienced tax advisors help tech and biotech companies properly account for venture capital, SAFE notes, and NIH or NSF grants while aligning tax planning with long-term growth strategies.
Stock options, RSUs, ISOs, NSOs, and founder equity require careful tax planning. Specialized tax services help avoid unexpected tax liabilities through strategies such as 83(b) elections, compensation modeling, and exit planning.
As companies scale and adopt remote work, they may trigger multi-state nexus issues. Advanced tax services help manage sales tax, payroll tax, income apportionment, and compliance across multiple jurisdictions.
Outsourced bookkeeping ensures accurate tracking of R&D expenses, grants, burn rate, and cash flow. Clean, standardized financial records improve audit readiness, investor confidence, and allow biotech teams to focus on research and innovation.
Offshore staffing helps reduce operational costs while maintaining quality in finance, accounting, payroll, and administrative functions. This approach extends the runway, improves efficiency, and supports scalable growth key factors for investor-backed biotech firms.